Production (Stage)
Encompass Health Corporation
EHC
$118.90
$0.290.24%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.51B | 5.37B | 5.22B | 5.07B | 4.96B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.51B | 5.37B | 5.22B | 5.07B | 4.96B |
| Cost of Revenue | 3.19B | 3.14B | 3.06B | 2.98B | 2.91B |
| Gross Profit | 2.32B | 2.23B | 2.16B | 2.10B | 2.05B |
| SG&A Expenses | 269.50M | 266.50M | 264.40M | 260.00M | 265.00M |
| Depreciation & Amortization | 308.50M | 299.60M | 291.70M | 280.60M | 280.30M |
| Other Operating Expenses | 816.20M | 792.20M | 770.60M | 751.90M | 734.70M |
| Total Operating Expenses | 4.59B | 4.50B | 4.38B | 4.27B | 4.19B |
| Operating Income | 924.00M | 874.90M | 832.50M | 802.80M | 771.10M |
| Income Before Tax | 809.80M | 749.60M | 713.00M | 674.20M | 639.40M |
| Income Tax Expenses | 153.50M | 150.20M | 149.80M | 144.10M | 138.60M |
| Earnings from Continuing Operations | 656.30 | 599.40 | 563.20 | 530.10 | 500.80 |
| Earnings from Discontinued Operations | -2.00M | -2.80M | -11.70M | -12.30M | -12.30M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -159.60M | -140.90M | -129.10M | -118.30M | -111.70M |
| Net Income | 494.70M | 455.70M | 422.40M | 399.50M | 376.80M |
| EBIT | 924.00M | 874.90M | 832.50M | 802.80M | 771.10M |
| EBITDA | 1.23B | 1.17B | 1.12B | 1.08B | 1.05B |
| EPS Basic | 4.91 | 4.53 | 4.20 | 3.98 | 3.76 |
| Normalized Basic EPS | 3.47 | 3.35 | 3.24 | 3.11 | 2.96 |
| EPS Diluted | 4.84 | 4.46 | 4.14 | 3.92 | 3.71 |
| Normalized Diluted EPS | 3.40 | 3.27 | 3.17 | 3.04 | 2.90 |
| Average Basic Shares Outstanding | 400.30M | 399.60M | 399.10M | 398.70M | 398.30M |
| Average Diluted Shares Outstanding | 408.50M | 408.60M | 407.80M | 407.10M | 406.20M |
| Dividend Per Share | 0.66 | 0.64 | 0.62 | 0.60 | 0.60 |
| Payout Ratio | 13.12% | 13.78% | 14.37% | 15.19% | 16.11% |